top of page

March 2023

HoLISTIC Consortium's Prognostic Model for Advanced Stage Lymphoma

January 2023

Novel Prognostic Model Appears Superior to IPS in Classical Hodgkin Lymphoma

January 2023

HoLISTIC Consortium Develops Reliable Predictive Model for 5-Year Survival in Classic Hodgkin Lymphoma

December 2022

Investigators Develop Model to Predict Overall Survival in Adults Diagnosed with Advanced Stage Hodgkin Lymphoma

November 2022

An insight into the HoLISTIC consortium and the value of international collaborations in HL

March 2022

$3.5 Million NIH Grant will Help Harness Worldwide Big Data to Enhance Decision Support in Hodgkin Lymphoma
National Cancer Institute Grant Awarded to Tufts Medical Center and Rutgers Cancer Institute of New Jersey Collaborators

July 2020

International Consortium Aims to Enhance Decision-Making in Hodgkin Lymphoma

May 2020

Building an International Consortium to Enhance Decision Making in Hodgkin Lymphoma

Dec 2019

ASH 2019 Interview - Prof Andrew Evens - HoLISTIC Hodgkin Lymphoma International Study

bottom of page